Frontier in Medical & Health Research
RELATIONSHIP BETWEEN VITAMIN D3 LEVELS AND ABNORMAL UTERINE BLEEDING
PDF

Keywords

Abnormal uterine bleeding, Vitamin D3 deficiency, Menorrhagia, Endometrial dysfunction

How to Cite

RELATIONSHIP BETWEEN VITAMIN D3 LEVELS AND ABNORMAL UTERINE BLEEDING. (2025). Frontier in Medical and Health Research, 3(3), 1412-1419. https://fmhr.net/index.php/fmhr/article/view/1750

Abstract

Background: Abnormal uterine bleeding (AUB) is one of the most frequent gynecologic complaints among women of reproductive age, leading to significant morbidity and reduced quality of life. Objective: To evaluate the relationship between serum vitamin D3 levels and abnormal uterine bleeding in women of reproductive age. Methodology: This cross-sectional study was conducted at the Obstetrics and Gynaecology Outpatient Department from August 2024 to January 2025. A total of 60 women aged 13–45 years presenting with AUB were included using non-probability consecutive sampling. The sample size was calculated using the WHO calculator, assuming a 95% confidence level, 10% precision, and 86% prevalence of vitamin D deficiency in AUB. Women who were pregnant, had thyroid disorders, were using hormonal contraception, or were taking vitamin D supplementation were excluded. All participants underwent history, examination, and relevant investigations including CBC, PT/INR, APTT, transvaginal ultrasound, thyroid function tests, and serum vitamin D3 measurement. Results: The mean age of participants was 31.2 ± 7.4 years, and the mean BMI was 27.5 ± 3.9 kg/m². Menorrhagia was the most common pattern, and the mean duration of bleeding was 8.6 months. Vitamin D3 deficiency was highly prevalent (71.66%) with a mean level of 17.2 ng/mL. Deficiency showed significant associations with higher BMI and longer bleeding duration but not with age or bleeding type.  Conclusion: It is concluded that vitamin D3 deficiency is highly prevalent among women with abnormal uterine bleeding and is significantly associated with obesity and prolonged duration of symptoms.

PDF